Dr. Alexander A. Dew
Overview
I specialize in the diagnosis and treatment of Multiple Myeloma and related blood cancers, including advanced options like stem cell transplants and CAR-T cell therapy. Before coming to Duke, I served as a blood cancer specialist and Director of the Autologous Stem Cell Transplant Program at Walter Reed National Military Medical Center, and have dedicated my career to helping patients battle these complex illnesses. My passion for this field stems from personal experience—losing my mother to Multiple Myeloma inspired me to improve treatments and guide patients through their cancer journey with compassion and hope. I treat a diverse range of patients, from newly diagnosed to those undergoing advanced therapies, always aiming to provide personalized, compassionate care. When I’m not working, I enjoy spending time with my family, hiking, and exploring all the Triangle has to offer.
Dr. Dew is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Monoclonal Gammopathy of Undetermined Significance (MGUS).
His clinical research consists of co-authoring 12 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Dew has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of North Carolina At Chapel Hill
Brandi Reeves is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Reeves is rated as a Distinguished provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Multiple Myeloma, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reeves is currently accepting new patients.
UT MD Anderson Cancer Center
Hesham Amin is a Hematologist in Cary, North Carolina. Dr. Amin is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Liver Cancer, POEMS Syndrome, T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), and Liver Embolization.
The Moses H Cone Memorial Hospital Operating Corporation
Yan Feng is a Hematologist Oncology specialist and a Hematologist in Reidsville, North Carolina. Dr. Feng is rated as a Distinguished provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Familial Colorectal Cancer, Paget Disease of the Breast, Gastroesophageal Junction Cancer, and Anal Cancer. Dr. Feng is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Smoldering Multiple MyelomaDr. Dew isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Dew isExperienced. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)